AM-3840

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAM-3840
Drug Alias NameAM-3840
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin S inhibitors
TargetsCathepsin S
Therapy Area/IndicationsNeuralgiaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmura Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmura Therapeutics
Active IndicationsN/A
Inactive IndicationsNeuralgiaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A